News About: Goverment
Korea's drug spending lowest in OECD
Koreans were found to have spent the least on drug expenditure among advanced countries.
The country's pharmaceutical expenditure per capita was equivalent to 49 percent of its gross domestic product (GDP) in...
Council rejected production obligations for small packaged drugs.
The Deregulation Council rejected an ordinance bill raised by the KFDA, of regulating the drug industry to obligate a small packaged drug production and supply on the ground of no accordance with the Working Rules of ...
Bill to describe prescription drugs in Hangul alphabet hits snag
On September 22, lawmakers of National Assembly's Health and Welfare Committee failed to reach an agreement on the description of antibiotics, steroids and psychotropic drugs in Hangul Alphabet in a prescription, as t...
Drug safety information center to be formed
With the Korea Food and Drug Administration (KFDA) to be disbanded and its responsibilities assigned to a new and an existing agency, the Ministry of Health and Welfare said recently it is considering a new establishm...
Immediate tariff free for 65.9% of drugs under bounded tariff memorandum.
According to the FTA bounded tariff memorandum exchanged between Korea and the U. S. during the 3rd talks, the tariffs for about 65.9% of imported drugs, two third of the total subjected drugs, should be free immediat...
Korea Food and Drug Administration to be disbanded
The Korea Food and Drug Administration (KFDA) will be disbanded, and instead a ministry for food safety will be set up to take charge of food safety in place of the current KFDA as part of the government's organizatio...
KFDA finally to determine Bio equivalency test review.
The KFDA finally determined that the bio equivalency tests for the total 600 drugs including 200 cases with uninterpretable data and 400 cases of no data should be reviewed after consultation with the legal experts, p...
Plans underway to speed up new biologicals license procedure
The government is considering shortening the period of new biological products in the process of screening their safety and efficacy by introducing the so-called mid-term assessment systemas part of its plan to ensure...
Domestic pharmaceutical firms should explore foreign markets with better R&D capacity
Korean drug makers need to reinforce their research and development (R&D) strategy toward modified new drugs and/or first generics to ensure that firms will be able to survive in the neck-and-neck international compet...
New gene therapy in Korea on the progress.
A gene therapeutic possibility showed quite a promising prospect by the local pharmaceutical industries including Dong-A, Yuhan and Kolon and the bio venture companies such as Biromed and Newgenepharm.
Biromed a...
